Antibiotics II – Flashcards
Unlock all answers in this set
Unlock answers
Tetracyclines |
Broad spectrum
1ST – Rickettsia, Chlamydia Good for intracellular bacteria because good penetration into host cells |
Tigecycline |
-drug resistant Gram neg & MRSA; not good for UTI or blood (newest derivative, a glyclglycine) |
Spectinomycin |
Spectinomycin: MOA similar to aminoglycosides (aminocyclitol); Binds to 30S but is bacteriostatic. |
Chloramphenicol |
Binds reversibly to 50S Prevents peptide bond formation BROAD SPECTRUM Toxic effects – Aplastic anemia |
Lincomycin and the derivative Clindamycin |
|
Macrolides |
|
Oxazolidinones Linezolid - ZYVOX
|
A synthetic antimicrobial agent that is the first in a new class of agents – designed from scratch. First new class in 40 years
Useful for Gram positive infections: First new drug for Staphylococcus infections in years. Tx: MRSA & VRE
Thought to attack an unexploited site: The proper assembly of the fmet-tRNA with mRNA and the 30S subunit. May also act by binding 50S and preventing 70S formation. TOTALLY NEW TARGET
Neither linezolid or its chemical relatives have been used for animal infections or as growth promoters. YET: resistance already reported (LRE/LRVRE)! |
Rifamycins (Rifampin=Rifampicin; cidal) |
|
Griseofulvin |
Fungistatic agent that affects fungal microtubles, inhibiting DNA replication and mitosis.
Ineffective if applied locally. Must be given orally – Collects in keratin. At the levels used, does not affect mammalian cells. |
Quinolones/Fluoroquinolones |
|
Metronidazole |
Anaerobes and Parasites: Must be reduced in the cytoplasm by a nitroreductase to become active (Use: Anaerobes, H. pylori, protozoa)
|
Intermediary Metabolism: Anti-folates |
Sulfonamides ------------> Synthetase Trimethoprim ----------> Dihydrofolate Reductase |
Mechanisms of Resistance |
1.Modification of the target so that it is insensitive to an inhibitor but still functions. 2.Duplication or replacement of the target enzyme 3.Prevent access to the target (efflux pump) 4.Depression of a metabolic activity that normally converts an inert agent into an active agent 5.**Synthesis of enzymes that inactivate an antimicrobial agent or modify the agent to alter entry or binding to a target |